| Similar Articles |
|---|
 |
Bio-IT World
June 15, 2003
Bob Violino |
Mid-Atlantic/Southeast Region Maryland: Making a Federal Case for Biotechnology... Puerto Rico: Isle of Incentives... Virginia: Planting Needed Seed Capital... North Carolina: Triangulating Biotech Resources... Florida: Shining Resources on Small Biotech Sector   |
CFO
December 1, 2006
Kate O'Sullivan |
Biotech Dreaming Cities and states in the U.S. are vying to become biotechnology hot spots. Ultimately, some regions may not have enough of the key ingredients for biotech success. |
IndustryWeek
August 1, 2002
Tonya Vinas |
Locations -- R.I. Plants To Supply Key Drug Immunex Corp. chooses West Greenwich for BioNext Project, which will produce Enbrel and other drugs for the growing biotech company. |
Bio-IT World
June 15, 2003
Bob Violino |
Northeast Region Massachusetts: University and Research Hub... Connecticut: Investing in Bio Facilities... New York: Biotech Empire State... New Jersey: Still Big Pharma Country... Pennsylvania: Life Sciences, a Keystone Industry |
National Real Estate Investor
June 1, 2003
H. Lee Murphy |
Who's Behind Biotech? There is a niche in the office market where vacancies are a fraction of the national rate, rents are way above average, and prospects for growth actually exist. It is the specialized (and regionally concentrated) business of supplying space to the biotech and life sciences industry. |
Bio-IT World
June 15, 2003
Barbara Depompa |
Northwest Region Colorado: Biotech Summit in Denver... Utah: A Mecca for Genealogical Research... Washington State: Therapeutics and Diagnostics Niche... |
Job Journal
September 21, 2003
Marty Nemko |
Biotech = Opportunity What this strong growth industry could offer you |
Bio-IT World
April 2006
Laura Huckabee-Jennings |
Southern Emergence Why Huntsville, Alabama, will be the next biotech hotbed. |
Inc.
May 1, 2002
Kenneth Klee |
The Industry You Can't Afford to Miss After more than two decades of hype, hope, disappointment, and progress, the hundreds of mostly small, money-burning companies that make up the biotech industry are experiencing a decisive shift in their relationship with the giant, rich pharmaceutical companies... |
Commercial Investment Real Estate
May/Jun 2005
Bell & Drummond |
Biotech Boom Biotech tenants have specific needs for lab/office space, but they do not need a physical link to a city's business center. In addition to biotech, the nanotech and biopharmaceutical industries are also growing quickly. |
Bio-IT World
October 14, 2004
Robinson & Violino |
Strategic Insights: Global Positioning International Economic Development for biotech companies in search of a better location or international presence, countries in Asia and Europe are offering a host of incentives, including tax credits and reduced red tape. |
Bio-IT World
June 15, 2003
Melissa Kruse |
Midwest/South Region Ohio: Outpacing U.S. in Bioscience Growth... Alabama: Sweet Home to Tech Tax Incentives... Kentucky: Investing Multimillions to Breed Bio Business... Minnesota: The 'Right Mix' of Talent and Funding... Tennessee: Pioneering Research Centers... Michigan: Teeming 'Life Sciences Corridor'... etc. |
IndustryWeek
March 1, 2005
Tonya Vinas |
Dell Strategy Includes U.S. Presence The computer manufacturer's North Carolina plant is one of three new U.S. sites to answer increasing demand for PCs. And the plant expects to employ 700 people in the first year of production -- and 1,500 people within five years. |
Bio-IT World
July 14, 2004 |
Not Just a Day at the Beach Joseph Panetta recalls leaving the comfort of a pharma job in Philadelphia for a position in biotech in San Diego, whose fledgling biotech community survived stormy nascent years to mushroom into a biotech hotbed. |
BusinessWeek
November 10, 2003
Arlene Weintraub |
Biotech Startups: Take Your Time Until products are close to approval, the public shouldn't share the risk |
Job Journal
July 16, 2006
Julia Hollister |
Biotech Boom The biotech field offers promising jobs in a profession that's expanding faster than you can spell biotherapeutics. |
Bio-IT World
June 15, 2003
Barbara Depompa |
Southwest Region Texas: Bioscience with a Space Spin... New Mexico: Building a Bioinformatics Niche... Arizona: Focus on Cancer and Neurological Therapy... Southern California: Deep Biotech Roots Grow Many Branches... Northern California: 'Can You Afford To Be Elsewhere?'... |
Entrepreneur
January 2008
Aliza Pilar Sherman |
The Boys' Club Although the situation is improving, there are still far fewer women entrepreneurs than men in the fast-growing biotech field. |
Job Journal
July 15, 2007
Rich Heintz |
Solano County Fast-growing Solano County offers affordable living and jobs aplenty. |
Managed Care
May 2004 |
Biologics Among Fastest Growers Managed care plans and pharmacy benefit managers can benefit from the strong generic presence in the market, but also face challenges relating to biotech drugs. |
BusinessWeek
June 13, 2005
Arlene Weintraub |
Why Biotech Stocks Are Sedated Biotech might seem like a can't-miss investing opportunity but many investors are taking a pass on biotech, even amid bona fide scientific advances. |
Bio-IT World
October 2006
Thomas G. Morr |
Eight Essential Elements for Commercial Success For life sciences companies both young and old, location is one of the critical success factors. With that in mind, here are eight essential considerations for life sciences executives when they are thinking of starting a business or opening a new location. |
Chemistry World
October 28, 2014
Phillip Broadwith |
Amgen stacks up additional job cuts US biotech heavyweight Amgen is to cut an extra 600 -- 1100 jobs by the end of 2015, on top of the 2900 the company earmarked for the chop in August. |
The Motley Fool
December 15, 2004
Brian Gorman |
Korea's Biotech Bet Korea's new facility could stimulate biotech research in Asia and lower costs for biotech companies. |
The Motley Fool
June 22, 2005
Brian Gorman |
Biotech's Global Agenda Bristol-Myers' recent outsourcing deal illustrates the global spread of biotech investments. |
The Motley Fool
August 18, 2008
Zoe Van Schyndel |
Funds for a Sick Economy? The biotech sector has been a sleeper with positive returns. Take a look at two biotech mutual funds that are performance leaders. |
The Motley Fool
February 23, 2005
Brian Gorman |
Amgen Gets Disciplined Direct-to-consumer advertising may be a non-starter for Amgen and other biotech companies. |
IndustryWeek
August 1, 2004
Tonya Vinas |
Making Waves Dubbed the 'third wave' of biotechnology, after medicine and agriculture, industrial biotechnology is promising to reshape manufacturing. |
Chemistry World
August 1, 2014
Sarah Houlton |
Amgen to shed 2400-2900 jobs Most of the job losses will be in the US, predominantly at the former Immunex research facility in Seattle and two biologics manufacturing sites in Colorado. |
The Motley Fool
June 21, 2005
Brian Gorman |
Genentech Hedges Its Edge The company's manufacturing capacity may allow it to attract biotech partners for years into the future. Investors, take note. |
IndustryWeek
April 1, 2007
John Teresko |
DuPont Does The DNA Dance Biotechnology is reshaping the world through our medicine, food, agriculture, materials and fuel. DuPont sees biotech as the ideal tool to improve productivity, quality and sustainability. |
The Motley Fool
November 16, 2006
Jim Fink |
The Best ETF for 2007: H&Q Life Sciences Investors H&Q Life Sciences, a health-care fund investing in one of the highest-growth sectors of the U.S. economy, is trading at a discount to NAV. Consequently, it's now primed to be the best-performing ETF for 2007. |
The Motley Fool
January 25, 2005
Charly Travers |
Grading Old-School Biotech Be very wary of biotech IPOs from companies lacking drugs. |
The Motley Fool
April 4, 2005
John Reeves |
Returns That Defy the Imagination Want to save lives while pursuing a high-growth investment strategy? Try exploring the biotech frontier. |
Bio-IT World
May 19, 2004
Barbara Depompa |
From Corn Belt to Bio Belt The Danforth Center in St. Louis attempts to lay the foundation for the local chamber of commerce's efforts to promote the region as a world-class location for plant and life science research. |
The Motley Fool
December 16, 2003
David Nierengarten |
Biotech's Next Phase It's been a great year for biotech, but don't count on a repeat in 2004. Here are some tips for evaluating biotechnology and pharmaceutical stocks. |
Pharmaceutical Executive
November 1, 2011 |
Turbulent Waters: M&As 2011 The latest numbers in pharma deals reveals a sector in transition, where market volatility has sharply degraded the appetite for risk. |
Bio-IT World
May 19, 2004
Barbara Depompa |
Surging in Seattle Laid-back coastal-mountain lifestyle bolsters Northwestern biotech company. |
Job Journal
August 8, 2004
Rich Heintz |
Biotech's Winning Formula for Steady Job Growth Deep pockets are creating expanding opportunities and biotechnology is helping to put America back to work. |
The Motley Fool
January 28, 2011
Luke Timmerman |
Merck, Staring at a Biotech Future, Seeks to Get in the Game With New Protein Drugs, Biosimilars Biotech drugs will soon dominate the pharmaceutical industry, and Merck is playing catch-up. |
BusinessWeek
June 13, 2005 |
Biotech's "Fantastic Future Ahead" Some bold predictions on what's coming for the biotech industry from Ernst & Young's Scott Morrison. |
HBS Working Knowledge
November 13, 2006
Sean Silverthorne |
Science Business: What Happened to Biotech? The biotech industry has underperformed expectations, caught in the conflicting objectives and requirements between science and business. |
Knowledge@Wharton
October 8, 2003 |
Biosciences: High Risk, High Reward, and the Potential for "Real Chaos" While bioscience researchers struggle to understand the workings of the human body, biotech managers and investors are searching for ways to better understand this complex and quickly evolving industry, according to Wharton faculty and lecturers. |
Pharmaceutical Executive
April 10, 2014
Christini & Kaitin |
Regional Trends in Bioinnovation Investment Can the Cambridge model be duplicated? |
The Motley Fool
April 4, 2009
Brian Orelli |
The Wrong Way to Invest in the Right Stocks Exchange-traded funds don't work for this industry. |
| Knowledge@Wharton |
The Benefits Are Mutual in New Wave of Biotech/Pharma Alliances The spat that erupted between pharma giant Bristol-Myers Squibb and biotech firm ImClone Systems over their partnership to develop a new cancer drug put the structure of alliances between discovery research firms and big drug makers under a microscope... |
Bio-IT World
May 19, 2004
Barbara Depompa |
Turning Sugar into Science The landmark building that housed the New England Confectionery Company in Revere, Mass. is being transformed into the new headquarters for the Novartis Institutes for BioMedical Research. |
Pharmaceutical Executive
September 1, 2005
Natasha Metzler |
You Raleigh Got Me A new convention center in North Carolina sets its sights on hosting medical meetings. |
BusinessWeek
March 26, 2007
Arlene Weintraub |
Biotech's Unlikely New Pal Can private equity manage its big risks and far-off returns? |
Chemistry World
April 4, 2013
Phillip Broadwith |
Regeneron expands, creating 400 new jobs US biotech Regeneron has announced that it will expand its corporate headquarters and laboratories in Tarrytown. |
